Ultra-processed foods and CKD: a review of evidence, limitations, and future directions.

Giulia Barbieri, Cristina Valle-Hita, Essi Hantikainen

Journal: Current opinion in lipidology 2025;37(1):7-13

PMID: 41452058

Abstract

PURPOSE OF REVIEW

To critically examine the emerging evidence linking ultra-processed food (UPF) consumption to chronic kidney disease (CKD), with a particular focus on prevention strategies, biological mechanisms, and implications for dietary guidelines and public health policy.

RECENT FINDINGS

Recent systematic reviews and meta-analyses consistently report a positive association between high UPF consumption and CKD risk. Mechanistic insights suggest roles for food additives, altered nutrient bioavailability, and inflammatory pathways, while omics-based studies offer preliminary biomarker candidates. The KDIGO 2024 guidelines now emphasize dietary interventions, including reduced UPF consumption, as a core component of CKD management.

SUMMARY

The findings support limiting UPF consumption as part of CKD prevention strategies. Nonetheless, the evidence base is largely derived from overlapping observational studies, with limited original research published in the considered timeframe. Moreover, the scarcity of recent original studies, methodological inconsistencies in UPF classification and CKD outcome definitions, highlight the urgent need for further research and standardization of approaches. Integrating precision nutrition and validated biomarkers into nephrology could enhance individualized dietary recommendations and public health interventions.

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

Address: Institute for Biomedicine, Eurac Research, Bolzano, Bozen, Italy.; Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Sciences.; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.; Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Sciences.; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.; Institute for Biomedicine, Eurac Research, Bolzano, Bozen, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.